Back
Celldex Therapeutics, Inc. 10K Form
Sell
48
CLDX
Celldex Therapeutics, Inc.
Last Price:
$29.61
Seasonality Move:
15.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLDX News And Ratings
See the #1 stock for the next 7 days that we like better than CLDX
CLDX Financial Statistics
Sales & Book Value
| Annual Sales: | $7M |
|---|---|
| Cash Flow: | $-49.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.01 |
| Price / Book: | 3.29 |
Profitability
| EPS (TTM): | -3.38200 |
|---|---|
| Net Income (TTM): | $-224.5M |
| Gross Margin: | $3.8M |
| Return on Equity: | -32.17% |
| Return on Assets: | -30.38% |
Celldex Therapeutics, Inc. Earnings Forecast
Key Celldex Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 38 years for CLDX is 54.74%.
-
The Selling, General & Administrative Expenses for CLDX have been equal to 549.12% of Gross Profit Margin.
-
The Research & Development expenses have been 2,284.52% of Revenue.
-
The Net Earning history of CLDX is -2,248.76% of Total Revenues.
-
Per Share Earnings over the last 39 years have been positive in 20 years.
Celldex Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLDX |
| CUSIP: | 15117B |
| Website: | celldex.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 13.01 |
| Quick Ratio: | 12.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLDX Technical Analysis vs Fundamental Analysis
Sell
48
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Is Celldex Therapeutics, Inc. a Buy or a Sell?
-
Celldex Therapeutics, Inc. stock is rated a SellThe current Celldex Therapeutics, Inc. [CLDX] share price is $29.60. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.